Home › Trial NCT05005845
NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)
- Trial IDNCT05005845
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorNFlection Therapeutics, Inc.
- Enrollment199
- Start date2021-09-29
- ConditionsCutaneous Neurofibroma · Neurofibromatosis 1
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.